AstraZeneca Posts an Arimidex DTC Ad on Its Corporate Blog – Will It Go...
AstraZeneca is breaking new ground in social media drug promotion... again. It has posted a branded promotion for its breast cancer drug Arimidex on...
Good Riddance to Old Guidance: FDA Intends to Purge & Revise. What It Means...
FDA has often said that developing guidance for applying regulations to social media is like nailing jelly to a tree. Actually, OPDP head Tom...
What You Mean “WE,” Kemosabe?
In this month's MM&M editorial titled "New dialogue, old hangups," Editor-in-Chief James Chase talks about the reluctance of the pharmaceutical industry to embrace digital...
Pharma Peeps: Stop Trying to Separate Your Personal and Professional Identities on Social Media...
Are you one of the pharmaceutical executives who have a Facebook, Twitter, or LinkedIn account? If so, you probably have disclaimers such as the...
OH MY GOD! DRUG SIDE EFFECTS KILLED KENNY!
I just received a press release in my email inbox announcing the creation of "South Park Pharmaceuticals." I kid you not!
WEST HILLS, N.Y., Aug....
Can a $5 Million per Quarter DTC Ad Campaign Turn Around an 8% to...
File this under "When pigs with wings fly." Let's do the math.
It has been reported (here) that Dendreon's Provenge sales were off 8% in...
Over-Drugged Medicaid Children
As reported in the Wall Street Journal (here):
"Federal health officials have launched a probe into the use of antipsychotic drugs on children in the...
72% of Online Adults Use Social Media, But Only 18% Use Twitter: Implications for...
According to Pew Research Center's Internet & American Life Project, 72% of online adults use social networking sites, but only 18% use Twitter. See...
Spit for Research: Will Genentech’s Online Promotion Succeed?
According to @Genentech, the official Twitter account of Genentech, “The #DNA in spit from cancer survivors may help scientists better understand cancer.” That being...
Are African-Americans More Distrustful of Clinical Trials Than All Other Americans? Depends on How...
I read with interest the piece "A Matter Of Trust: Minorities Are Suspicious Of Clinical Trials" by Ed Silverman, author of Pharmalot blog. The...
